Correlation Between Anebulo Pharmaceuticals and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Inhibrx, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Inhibrx.
Diversification Opportunities for Anebulo Pharmaceuticals and Inhibrx
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Anebulo and Inhibrx is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Inhibrx go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Inhibrx
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 2.3 times more return on investment than Inhibrx. However, Anebulo Pharmaceuticals is 2.3 times more volatile than Inhibrx. It trades about 0.0 of its potential returns per unit of risk. Inhibrx is currently generating about -0.01 per unit of risk. If you would invest 214.00 in Anebulo Pharmaceuticals on August 31, 2024 and sell it today you would lose (71.00) from holding Anebulo Pharmaceuticals or give up 33.18% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Anebulo Pharmaceuticals vs. Inhibrx
Performance |
Timeline |
Anebulo Pharmaceuticals |
Inhibrx |
Anebulo Pharmaceuticals and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Anebulo Pharmaceuticals and Inhibrx
The main advantage of trading using opposite Anebulo Pharmaceuticals and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Anebulo Pharmaceuticals vs. Cue Biopharma | Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. Inhibrx | Anebulo Pharmaceuticals vs. Molecular Partners AG |
Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |